NanoViricides Inc., a Shelton-based company that has developed drugs to fight such viruses as Ebola and HIV, expects to have an effective experimental COVID-19 coronavirus treatment ready for patients diagnosed with the disease in as little as six weeks.
Joe DeLong, CCM Executive Director, says you have to look at each individual community and make sure that the technology is broad enough and meeting all of the government compliance issues. At the same time, is the technology large enough and broad enough to meet the audience it is intended to engage?
Federal and state officials have responded with financial help. The Lamont administration announced recently a $50 million state aid package with no-interest loans available to Connecticut businesses and nonprofits with 100 or fewer employees. The loan are up to the lesser of three months operating expenses or $75,000.
“As of right now, it looks like it’s going to be very difficult to convene the legislature before the constitutional adjournment,” said House Speaker Joe Aresimowicz, D-Berlin, who is serving his last term.